These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35472505)

  • 1. Discovery of 3, 6-disubstituted isobenzofuran-1(3H)-ones as novel inhibitors of monoamine oxidases.
    Liu K; Zhou S; Zhou J; Bo R; Wang X; Xu T; Yuan Y; Xu B
    Bioorg Med Chem Lett; 2022 Jul; 67():128748. PubMed ID: 35472505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
    Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
    ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies.
    Zaib S; Rizvi SU; Aslam S; Ahmad M; Ali Abid SM; Al-Rashida M; Iqbal J
    Med Chem; 2015; 11(6):580-9. PubMed ID: 25541744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
    Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ
    Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
    Tripathi RK; Krishnamurthy S; Ayyannan SR
    ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
    Takao K; Saito T; Chikuda D; Sugita Y
    Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Tok F; Uğraş Z; Sağlık BN; Özkay Y; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
    Bioorg Chem; 2021 Jul; 112():104917. PubMed ID: 33932769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoamine oxidase inhibition properties of C6-mono- and N3/C6-disubstituted derivatives of 4(3H)-quinazolinone.
    Qhobosheane MA; Legoabe LJ; Petzer A; Petzer JP
    Bioorg Chem; 2019 Apr; 85():60-65. PubMed ID: 30599413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
    Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of N-methyl-propargylamine derivates as isoform-selective monoamine oxidases inhibitors for the treatment of nervous system diseases.
    Zhang K; Liu Y; Jia H; Wang H; Deng M; Liu Y; Zhao X; Xiu X; Li Z; Yang H; Cheng M
    Bioorg Chem; 2023 May; 134():106441. PubMed ID: 36854233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif.
    Pisani L; Farina R; Soto-Otero R; Denora N; Mangiatordi GF; Nicolotti O; Mendez-Alvarez E; Altomare CD; Catto M; Carotti A
    Molecules; 2016 Mar; 21(3):362. PubMed ID: 26999091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
    Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
    Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors.
    Takao K; U S; Kamauchi H; Sugita Y
    Bioorg Chem; 2019 Jun; 87():594-600. PubMed ID: 30933784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.
    Sterling J; Herzig Y; Goren T; Finkelstein N; Lerner D; Goldenberg W; Miskolczi I; Molnar S; Rantal F; Tamas T; Toth G; Zagyva A; Zekany A; Finberg J; Lavian G; Gross A; Friedman R; Razin M; Huang W; Krais B; Chorev M; Youdim MB; Weinstock M
    J Med Chem; 2002 Nov; 45(24):5260-79. PubMed ID: 12431053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides.
    Jana S; Nasreen T; Singh SK
    Future Med Chem; 2023 Jan; 15(2):189-210. PubMed ID: 36799336
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Lourens AC; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7367-70. PubMed ID: 23122857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.